4 Results for "

acute enteritis

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "acute enteritis" in MCE Product Catalog:

Cat. No.: HY-A0248B
CAS No.: 34503-87-2
Target:  

Antibiotic Bacterial

Research Areas:  

Infection Inflammation/Immunology

Polymyxin B2 is a polypeptide antibiotic with particularly potent antibacterial activity against Gram-negative bacteria. Polymyxin B2 kills bacteria by binding to lipopolysaccharide molecules on the bacterial cell membrane, disrupting membrane integrity and causing leakage of intracellular contents. Polymyxin B2 is used in studies related to Pseudomonas aeruginosa infection and acute enteritis .
loading...
    loading...
Cat. No.: HY-A0248C
CAS No.: 108965-69-1
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Polymyxin B2 Sulfate is a polypeptide antibiotic with particularly potent antibacterial activity against Gram-negative bacteria. Polymyxin B2 Sulfate kills bacteria by binding to lipopolysaccharide molecules on the bacterial cell membrane, disrupting membrane integrity and causing leakage of intracellular contents. Polymyxin B2 Sulfate is used in studies related to Pseudomonas aeruginosa infection and acute enteritis .
loading...
    loading...
Cat. No.: HY-A0248BR
CAS No.: 34503-87-2
Research Areas:  

Infection

Polymyxin B2 (Standard) is the analytical standard of Polymyxin B2 (HY-A0248B). This product is intended for research and analytical applications. Polymyxin B2 is a polypeptide antibiotic with particularly potent antibacterial activity against Gram-negative bacteria. Polymyxin B2 kills bacteria by binding to lipopolysaccharide molecules on the bacterial cell membrane, disrupting membrane integrity and causing leakage of intracellular contents. Polymyxin B2 is used in studies related to Pseudomonas aeruginosa infection and acute enteritis .
loading...
    loading...
Cat. No.: HY-P10914
CAS No.: 1426227-11-3
Target:  

MDM-2/p53 Autophagy

Research Areas:  

Inflammation/Immunology Cancer

D-CopA3 is the inhibitor for MDM2 and the activator for p53 signaling pathway. D-CopA3 exhibits cytotoxicity in colorectal cancer cells HCT-116, LoVo, and RKO (IC50=15-18 μM), induces JNK/Beclin-1 mediated autophagy. D-CopA3 downregulates the expression of cell cycle inhibitory protein p21Cip1/Waf1, enhances the mucosal barrier function and reduces penetration of inflammatory mediators. D-CopA3 exhibits anti-inflammtory activity in mouse C. difficile toxin A-induced acute enteritis models and DSS (HY-116282)-induced chronic colitis models. D-CopA3 exhibits antitumor efficacy in mouse HCT-116 xenograft models .
loading...
    loading...